Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: Impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients

Blood

Volumn 88, Issue 3, 1996, Pages 1104-1112

  Sekhsaria, Sudhir ^b   Fleisher, Thomas A ^b   Vowells, Sarah ^b   Brown, Margaret ^b   Miller, Judi ^b   Gordon, Inglese ^b   Blaese, R Michael ^b   Dunbar, Cynthia E ^b   Leitman, Susan ^b   Malech, Harry L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME DEFICIENCY; GENE TRANSFER; GRANULOMATOSIS; HEMATOPOIESIS; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL;

EID: 10144231442     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.1104.bloodjournal8831104     Document Type: Article

References (47)

1. Mccredie KB, Hersh EM, Freireich EJ: Cells capable of colony formation in the peripheral blood of man. Science 171:293, 1971
2. Gabbianelli M, Sargiocomo M, Pelosi E, Testa U, Isacchi H, Peschle C: "Pure" human hematopoietic progenitors: Permissive action of basic fibroblast growth factor. Science 249:1561, 1990
3. Sekhsaria S, Malech HL: Recombinant human stem cell factor enhances myeloid colony growth from human peripheral blood progenitors. Blood 81:2125, 1993
4. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwanz JF, Shaper JH: A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984
5. Sutherland RD, Keating A: The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1:115, 1992
6. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R: Successful autografting following myeloablative conditioning therapy with blood cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 21:504, 1993
7. Mohle R, Pforsich M, Witt B, Kramer A, Haas R: Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant 14:827, 1994
8. Van Epps De, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J: Harvesting, characterization and culture of CD34+ cells from human bone marrow, peripheral blood and cord blood. Blood Cells 20:411, 1994
9. + cells mobilized by four different protocols and those of steady phase PB and bone marrow CD34+ cells. Blood 84:2930, 1994
10. Molineux G, Pojcla Z, Hampson IN, Lord BI, Dexter TM: Transplantation potential of peripheral blood stem cells induced by granulocyte colony stimulating factor. Blood 76:2153, 1990
11. Kessinger A, Armitage JO: The evolving role of autologous peripheral blood stem cell transplantation following high dose therapy for malignancies. Blood 77:211, 1991
12. Vose JM, Anderson JR, Kessinger A, Bierman PJ, Coccia P, Reed EC, Gordon B, Armitage JO: High dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846, 1993
13. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Pelaez J, Reich E, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Frei E III, Antman KH: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony stimulating factor for hematologic support after high dose intensification for breast cancer. Blood 79:3036, 1992
14. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339:640, 1992
15. Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W: Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocytic-macrophagic colony stimulating factor. Exp Hematol 18:94, 1990
16. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
17. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantages of blood over marrow allografts. Blood 85:1659, 1995
18. Schmilz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
19. phox deficient chronic granulomatous disease. Proc Natl Acad Sci USA 90:7446, 1993
20. 558 defective forms of chronic granulomatous disease. Blood 84:53, 1994
21. Cassel A, Cottier-Fox M, Doren S, Dunbar CE: Retrtoviral mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 21:585, 1993
22. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418, 1992
23. Stoeckert CJ Jr, Nicolaides NC, Haines KM, Surrey S, Bayever E: Retroviral transfer of genes into erythroid progenitors derived from human peripheral blood. Exp Hematol 18:1164, 1990
24. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into peripheral blood of normal donors by granulocytemacrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
25. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 84:2795, 1994
26. Schinger W, Mache C, Urban C, Beufort F, Toglofer W: Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant 11:489, 1993
27. Malech HL: Phagocyte oxidative mechanisms. Curr Opin Hematol 1:123, 1993
28. Malech HL, Gallin JI: Current concepts: Immunology. Neutrophils in human diseases. N Engl J Med 317:687, 1987
29. Gallin JI, Malech HL: Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy. JAMA 263:1533, 1990
30. Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, Parkos CA: The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327:717, 1987
31. Clark RA, Malech HL, Gallin JI, Nunoi H, Volpp BD, Pearson DW, Nauseef WM, Curnutte JT: Genetic variants of chronic granulomatous disease: Prevalence of deficiencies of the two cytosolic components of the NADPH oxidase system. N Engl J Med 321:647, 1989
32. Orkin SH, Daddona PE, Shewach DS, Markham AF, Bruns GA, Goff SC, Kelley WN: Molecular cloning of human adenosine deaminase gene sequences. J Biol Chem 158:12753, 1983
33. Bonthron DT, Markham AF, Ginsburg D, Orkin SH: Idemification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency. J Clin Invest 76:894, 1985
34. Hirschhorn R: Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: Overview, genetic heterogeneity and therapy. Birth Defects 19:73, 1983
35. Shapiro HM: How flow cytometers work, in Shapiro HM (ed): Practical Flow Cytometry (ed 3). New York, NY, Wiley-Liss, 1995
36. Owens MA, Loken MR: Peripheral blood stem cell quantitation, in Owens MA, Loken MR (eds): Flow Cytometry Principles for Clinical Laboratory Practice. New York, NY, Wiley-Liss, 1995
37. Loken MR, Brosnan JM, Bach BA, Ault KA: Establishing optimal lymphocyte gates for immunophenotyping for flow cytometry. Cytometry 11:453, 1990
38. - progenitor cells. Blood 77:1218, 1991
39. Huang S, Terstappen LWMM: Formation of both hematopoietic microenvironment and hematopoietic stem cells from single human marrow stem cells. Nature 360:745, 1992
40. - hematopoietic stem cells. Blood 83:1515, 1994
41. Terstappen LWMM, Huang S, Picker LJ: Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. Blood 79:666, 1992
42. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow: Normal B lymphocyte development. Blood 70:1316, 1987
43. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow: Normal erythroid development. Blood 69:255, 1987
44. Hogg N, MacDonald S, Slusarenkom M, Beverley PCL: Monoclonal antibodies specific for human monocytes, granulocytes and endothelium. Immunology 53:753, 1985
45. Brugger W, Henschler R, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high dose VP16, ifosamide, carboplatin and epirubicin. Blood 84:1421, 1994
46. + cell content predicts engraftment following allogeneic and autologous hematopoietic stem cell transplantation. Blood 84:87a, 1994 (abstr, suppl 1)
47. Begley CG, Basser R, Mansfield R, Maher D, To B, Juttner C, Fox R, Cebon J, Grigg A, Szer J, McGrath K, Thomson B, Sheridan W, Menchaca D, Collins J, Russell I, Green M: Randomized prospective study demonstrating a prolonged effect of SCF with G-CSF (Filgrastim) on PBPC in untreated patients: Early results. Blood 84:25a, 1994 (abstr, suppl 1)